Alvotech (ALVO) Deferred Taxes (2021 - 2026)
Alvotech's (ALVO) quarterly Deferred Taxes came in at -$44000.0 in Q1 2026, up 99.73% YoY from -$22029.8 in Q1 2025, and up 94.73% on a QoQ basis from -$835000.0 in Q3 2025.
Alvotech (ALVO) Deferred Taxes (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Deferred Taxes data on file, last reported at -$44000.0 in Q1 2026.
- Quarterly Deferred Taxes rose 99.73% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.9 million (down 964.51% YoY) and the FY2023 annual result came in at -$99.3 million, down 160.9% from the prior year.
- Deferred Taxes advanced to -$44000.0 in Q1 2026, from -$835000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $14.3 million in Q4 2024 to a low of -$99.3 million in Q4 2023.
- A 5-year average of -$17.0 million and a median of -$14.8 million in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes plunged 14685.06% — and 2024, when it jumped 156.51%.
- Tracing ALVO's Deferred Taxes over 5 years: stood at -$38.1 million in 2022, then tumbled by 160.9% to -$99.3 million in 2023, then soared by 114.4% to $14.3 million in 2024, then slumped by 105.84% to -$835000.0 in 2025, then soared by 94.73% to -$44000.0 in 2026.
- The last three Deferred Taxes figures came in at -$44000.0 (Q1 2026), -$835000.0 (Q3 2025), and -$22.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Sep 30, 2025 | -835,000.00 |
| Jun 30, 2025 | -22.73 Mn |
| Mar 31, 2025 | -16.26 Mn |
| Dec 31, 2024 | 14.30 Mn |
| Sep 30, 2024 | -13.36 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Mar 31, 2024 | -6.44 Mn |
| Dec 31, 2023 | -99.32 Mn |
| Jun 30, 2023 | -20.47 Mn |
| Mar 31, 2023 | -29.38 Mn |
| Dec 31, 2022 | -38.07 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | -18.16 Mn |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | -22.04 Mn |